
|Articles|December 1, 2004
FDA safety oversight under scrutiny
Recent scares about suicidality linked to antidepressants and painkillers intensifying interest in policies to ensure the safe use.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement























